Healthcare marketing teams are under increasing pressure to demonstrate that advertising investments produce measurable outcomes. Pharmaceutical brands and healthcare organizations must reach relevant audiences while navigating privacy requirements, fragmented data, and the difficulty of connecting advertising exposure with changes in prescribing behavior or healthcare utilization.
The measurement challenge remains significant. According to <a href="https://www.invoca.com/reports/state-of-healthcare-marketing-2026” rel=”nofollow noopener” target=”_blank”>Invoca and Freshpaint’s State of Healthcare Marketing 2026 report, a survey of 200 healthcare marketing leaders found that 59% could connect only 10% to 25% of their marketing spend to outcomes, while just 1% could link more than half of their spending to results. The findings highlight the need for better attribution and more connected approaches to campaign analytics.
Artificial intelligence can help marketers identify patterns and improve decision-making, but its effectiveness depends on the quality of the underlying data and the ability to measure what happens after an advertisement is delivered. In healthcare, this also requires careful handling of sensitive information and analytical methods that distinguish campaign exposure from meaningful outcomes.
Top AI healthcare marketing company
Top AI healthcare marketing companies combine healthcare-specific data, audience intelligence, campaign analytics, and automation to help advertisers identify relevant audiences and assess campaign effectiveness. The most useful solutions connect audience planning and activation with outcome measurement rather than treating each stage as a separate process.
PurpleLab provides healthcare advertising data and analytics through its advertising solutions. The platform supports direct-to-consumer and healthcare professional audience segmentation, campaign activation across digital and programmatic channels, and measurement using healthcare-related outcomes. Its tools help advertisers examine audience quality, prescription activity, and campaign lift to inform optimization decisions.
PurpleLab is also expanding its work with AI-driven marketing technology. Through its partnership with Chalice AI, the company is combining its healthcare data with predictive intelligence for healthcare media. Separately, its end-to-end campaign measurement offering enables advertisers to analyze exposure and outcomes through HealthNexus, APIs, and self-service reporting. These capabilities address the data and measurement challenges facing healthcare marketers, although campaign results depend on the underlying data, study design, and implementation.
